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ABSTRACT
Candida species were discovered more than a century ago as a causative
organism of oral thrush. In HIV patients, the presence of oral candidiasis has
been shown to be the earliest opportunistic infection. Candidiasis lesions
associated with HIV infections are primarily a reflection of the specific change
of the host's immune response caused by the virus. Studies of AIDS all over
the world show that 58-81 % of all patients contract a fungal infection at some
time during the primordial stage or after developing AIDS and 10-20% have
died as a direct consequence of fungal infections.
Twenty four South African medicinal plants were screened uSing a
modification of the NCCSL broth microdilution antifungal test against Candida
albicans standard strain ATCC 10231 and two clinical isolates from a 5-
month-old baby and an adult. This assay was performed in order to find a
traditional remedy to treat oral candidiasis. Of all the screened plants Allium
sativum L., Glycyrrhiza glabra L., Polygala myrtifolia L. and Tulbaghia violacea
L. aqueous extracts were found to have the best activity. Allium sativum and
Tulbaghia violacea aqueous bulb extracts had MIC values of 0.56 mgmr1 and
3.25 mgmr1 respectively, whilst Polygala myrtifolia leaf extracts and
Glycyrrhiza glabra rhizome extracts had MIC values of 1.56 mgmr1 and 3.25
mgmr
1
respectively when tested against the isolate from a 5-month-old baby,
which was the most susceptible of the isolates used. All the extracts had
xii
higher MIC values against the standard strain (ATTC 10231), which was the
least susceptible to the extracts Llsed.
Stability testing was performed on fresh aqueous extracts of A. sativum, G.
glabra, T. violacea and P. myrtifolia stored at 4°C, 23°C and 33°C over a
period of one week, to determine the stability of the extracts in solution. All A.
sativum extracts maintained stability for three days in solution, whilst T.
violacea extracts remained stable for only two days in solution. TLC
fingerprinting of A. sativum and T. violacea extracts indicated the presence of
the known antibacterial and antifungal compound allicin. The activity of allicin
and other active compounds was observed by using the bioautographic
assay, which was performed on these extracts.
P. myrtifolia and G. glabra extracts lost stability 24 hours after preparation at
all tested temperatures. However, it was clear with the four plant extracts
tested that storage of solutions at higher temperatures reduced their activity
and stability.
The unpleasant taste and smell of A. sativum and G. glabra could however
not be masked, since the intake of these two extracts would result in HIV-
patients being recognised. These two plants where therefore not considered
for further investigation. G. glabra and P. myrtifolia are both saponin
containing plants. These could be the active constituents responsible for the
anticandidal action. G. glabra is known for its biological activity as an
antibacterial agent, whilst other Polygala species have been reported to
xiii
possess antifungal saponins. Although P. myrtifolia and G. glabra are not
stable for more than 24 hours, they do not have an unpleasant smell or taste.
These plants are therefore further investigated for use as oral mouthwash in
clinics and homes.
CHAPTER 1
ETHNOBOTANY AND DRUG DISCOVERY
1.1 Project Rationale
An approach by the Staff of Christ the King Hospital, located in Ixopo South
Africa led to the initiation of this project. The hospital had severe cases of
patients infected with oral candidiasis, especially babies. The number of
people coming to the hospital is overwhelming, with most of the patients being
admitted for a number of days. Most of the child patients have such severe
infections of oral candidiasis that feeding is a problem. The feeding problem
further compromises their condition as HIV positive people. Shortage of
medication (antifungal drugs) aggravates the situation, and even when
treatment is available most patients would return to hospital within two to three
weeks with recurring symptoms.
After the initiation of this project Pfizer Pharmaceuticals made available the
antifungal drug "Diflucan" (fluconazole), to state hospitals for HIV/AIDS
patients in South Africa at no cost for a period of two years. However, the drug
is only made available for severe or "life threatening" cases of candidiasis. As
a result, the matter is serious, since many rural patients require readily
available medication. Other available antifungal drugs, which could be
prescribed to patients, are usually expensive. It is therefore evident that for
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those patients where symptoms of oral candidiasis reoccur, and for cases
where the microorganism has developed resistance to existing drugs,
alternative medication is urgently required.
1.2 Ethnobotany and Traditional Medicine
Eighty five percent of traditional medicines are derived from plants and their
extracts. Natural compounds, their derivatives and analogues still represent
over 50% of all drugs in clinical use, with higher plant derived natural products
representing 25% of the total (BALANDRIN et al., 1993). Extracts of some
plants are useful in a crude form, i.e. Atropa belladonna tincture as an
antispasmodic, Rauvolfia serpentina roots for hypertension and as a
tranquilizer, and Papaver somniferum extracts or tincutures as an analgesic
(FARNSWORTH AND SOEJARTO, 1991).
For more than two decades the World Health Organisation (WHO) has
encouraged the use of traditional medicine, especially in the developing
countries by promoting the incorporation of useful elements into national
healthcare systems (SINDIGA, 1995). It is estimated that 80% of the world
population in less developed countries rely on traditional medicine as their
sole primary health resource (FARNSWORTH, 1994). It is therefore essential
that traditional medicine be promoted and plants be studied for safety and
efficiency and to develop galenical products that are standardized and stable
(FARNSWORTH, 1994). Promotion of herbal medicine at the national level
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aims primarily at improving drug supply, lowering the cost for drugs and import
constituents (GRAND AND WONDERGEM, 1989). At community levels
promotional activities are focused on self-reliance, community participation
and strengthening of local medical traditions as a whole (GRAND AND
WONDERGEM, 1989).
The popularity of herbs and other alternative therapies is rising significantly
worldwide. A survey conducted in the U.S. in 1997 showed that 42% of the
people surveyed reported using some form of alternative medicine and
herbal remedies showed the highest use increase (MORSIDONI, et al., 2001).
Despite the dramatic advances and advantages of conventional medicine, it is
clear that herbal medicine has much to offer. Over the years, infectious
organisms have developed resistance to synthesized drugs, and active
constituents from herbs like Artemisia annua are being used to treat malaria in
areas of the world where the protozoa causing the infection no longer respond
to conventional treatment (CHEVALLlER, 1996). Herbal medicine often
complements conventional treatments, providing safe, well-tolerated remedies
for chronic illnesses (CHEVALLlER, 1996).
1.3 Traditional Medicine in South Africa
South Africa has a rich cultural diversity that is reflected in the formal and
informal systems of medicine that is presently practised in different parts of
the country. There are an estimated 2C?o 000 indigenous traditional healers in
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South Africa and up to 60% of the South Africans consult them (VAN WYK, et
al., 1997). These traditional healers are commonly divided into three types: 1.
inyanga (herbalist); 2. isangoma (diviners) and 3. umthakathi (sorcerer)
(PANTANOWITZ, 1994). These people are believed to be spiritually
empowered and use these powers with plant extracts as remedies to heal
patients (VAN WYK et al., 1997).
Traditional healing provides for the primary health care needs of a large
number of the black population in South Africa, and 80% of the Zulu
population seen by medical practitioners also consult with traditional healers
(JAGER et al., 1996; VAN WYK et al., 1997). It is therefore estimated that
there are 27 million consumers of traditional medicine in South Africa
(MANDER, 1998). In KwaZulu-Natal alone over 400 plants are actively traded
with an estimated trade volume of some 4 300 tonnes per year. Households
are spending between 4% to 8% of their annual income on indigenous
medicine and services (MANDER, 1998).
A large number of South African medicinal plants are widely used by
traditional healers for their ability to cure a lot of the infectious diseases.
Researchers in the ethnobotanical field have screened many of these plants
for activity against bacteria, and fungi (COX AND BALlCK, 1992). However,
there has been little research performed on the activity of indigenous
medicinal plants against the fungal species Candida albicans.
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1.4 Infectious Diseases and Traditional Medicine
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Infectious diseases account for a large proportion of the health problems in
Africa (DESTA, 1993). A large number of traditional healers are using the
diverse plant material at their disposal for the treatment of these diseases.
With the knowledge these traditional healers have on medicinal plants, new
and interesting natural products may well be discovered. Biologically active
compounds could be isolated by bioassay-guided fractionation procedures in
which various screening methods are employed to identify the biologically
active compounds from crude extracts (MARSTON et al., 1993).
1.5 The Threat and Conservation of Medicinal Plants
The importance of medicinal plants has been briefly outlined in the above
paragraphs. The demand for indigenous medicine and medicinal plants is
extensive, mostly by the black population and especially in KwaZulu-Natal
(MANDER, 1998). Professional herb collectors and traditional healers have
had a considerable impact on wild plant populations and the following result:
• Active trade and marketing of medicinal plant material;
• Fragmented distribution of medicinal plant species due to varied land
use, topography and climate in the region;
• Large spatial concentrations of consumer demand;
• Local extinctions of plant populations and therefore the need to access
more remote plant populations due to intensive harvesting; and
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• The inadequate access to health care by rural communities, which
when lacking maintains and stimulates demand (MANDER, 1998).
It is estimated that 340 tonnes of plants are traded through shops per year,
with approximately 50% purchased directly from plant gathers (170 tones) and
the remaining 50% purchased from street traders. These figures highlight the
demand for indigenous medicine, which is estimated to increase with a
population increase. The rapid increase of AIDS in South Africa also lead to
an increased demand on traditional medicines since patients obtain little relief
from western medicine prescriptions (MANDER, 1998). The demand is not
only escalated by black patient use in rural communities but also
pharmaceutical companies currently developing products for the African
market in South Africa (MANDER, 1998).
The indigenous medicine market is based on indigenous plants, which are
generally harvested from wild plant stocks throughout South Africa and
neighbouring countries. Harvested plant stocks are not managed and little
cultivation takes place. Wide ranges of plant species are showing indications
of unsustainable use. This is visible through the decreased availability of plant
products in the market, distances of collecting stocks increasing and
availability of products becoming increasingly erratic in certain markets. The
scarcity of popular plants and under-supply in some markets resulted
considerable increases in product costs (MANDER, 1998).
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Despite the fact that the fate of plants does not look bright, there are however
methods which could be used to sustain the supply of plants to the markets or
to ensure that the plants are not over exploited. These methods include
effective management of grasslands, woodlands, thickets and private property
that have not been intensively exploited. Proper storage facilities and trading
infrastructure could lead to less wastage of already collected plant material,
leading to less frequent harvesting (MANDER, 1998). Lastly, cultivation of





Candida albicans is a yeast-like microorganism with fungal characteristics
(SALTARELLI, 1989). The vegetative cells of C. albicans were first described
in 1853 as spherical or broadly oval shape 2-8.5 ~m to 3.0-14 ~m in size and
able to reproduces by multilateral budding. C. albicans can live on many other
living organisms without inducing problems however; it may invade and cause
infections and death in humans and animals (SALTARELLI, 1989). In humans
it is mainly found in warm, dark, moist areas of the body. Antibiotics, steroid-
hormones, birth control pills, excessive stress and too much sugar in the diet
cause the yeast to overgrow. When C. albicans becomes active, it can affect
every part of the body. Its toxins can even affect the brain and blood stream
(BURTON, 1989). It is estimated that one out of three people in the Western
world have Candida infections. This disease affects women, men, boys, girls
and even babies, showing mild symptoms or even chronic conditions
(BURTON, 1989).
Candida is a dimorphic fungus able to grow in the yeast and mycelium forms.
This feature is associated with the morphological changes in the pathogenic
fungus in that the morphology of the fungus in the infected tissue is different
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from that of the propagule, which initiated the infection. This altering of
morphology in the pathological state is also associated with the survival
advantage of the fungus (SHEPHERD, 1991). The dimorphic nature of this
yeast may therefore, be defined as an environmentally controlled reversible
transition between yeast and mycelium forms (SALTARELLI, 1989).
The nutritional requirements of C. albicans in vitro are comparatively simple
and as follows: A medium composed of glucose, (NH4hS04, biotin and
inorganic salts supports maximal growth of several different strains. The
morphology of Candida is based on controllable modifications of well-defined
media, with the organism growing at a wide range of pH, but flourishes best at
pH 7 (SALTARELLI, 1989).
As mentioned Candida is a morphologically changing organism, therefore a
number of external factors affect its existence and survival. Several
environmental factors of which the most frequently cited are inoculum size,
duration of incubation and medium composition are known to influence the
outcome of susceptibility tests in vitro (ODDS, 1993).
Special attention should be taken with the strains to ensure that the correct
morphological structure of the fungus is being used, ensuring that the
inhibitory activity is not selective for only one of the yeast or mycelium stages.
Temperature is another variable that influences the antifungal MIC's of yeasts
in broth dilutions and should be well considered (ODDS, 1993).
Chapter 2 Candida albicans review
2.2 Candida albicans in HIV/AIDS Patients
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HIV/AIDS has become a devastating epidemic. Sub-Saharan Africa has 10%
of the world's population and yet 70% of the global HIV burden and 90% of
the deaths attributable to HIV/AIDS occur in this region. Of the estimated 13.2
million children orphaned due to AIDS, 12.1 million are Africans (MARSHALL,
2001). According to the UN, South Africa has the fastest HIV/AIDS growth in
the world, with more than 4.5 million people diagnosed HIV positive,
thousands of AIDS deaths, 2500 new infections daily and 100-150 000 AIDS
orphans in the year 2000 alone (STEGMANN, 2001). Today AIDS accounts
for nearly a third of all deaths nationally and more than 40% in KwaZulu-Natal
i.e. some 500 deaths a day in total (MASLAN, 2001). A KwaZulu-Natal
voluntary survey of University students demonstrated infection rates of 26% in
women and 12% in men aged between 20 and 24, and 36% in women and
23% in men aged 25 to 29. This therefore emphasizes the need for top priority
on prevention programmes for young people (Urban Health and Development,
2000).
Studies of AIDS all over the world show that 58-81 % of all patients contract a
fungal infection at some time during the primordial stage or after developing
AIDS and 10-20 % die as a direct consequence of fungal infections
(DROUHET AND DUPONT, 1989). The presence of oral candidiasis is
considered the earliest of the opportunist infections (FAN-HARVARD et al.,
1991 ).
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The natural history of HIV/AIDS is that it weakens the immune system, which
renders the patients susceptible to a host of infections (DUBE AND
MUTLOANE, 2001). Treatment of the opportunistic infections can make a
large difference to the life quality of HIV-positive individuals. The best and
most effective way to keep HIV-positive individuals healthy is to prevent and
contain infection.
Candida was discovered more than a century ago as a causative organism of
oral thrush (PRASAD, 1991). The yeast-like forms of the organism are non-
invasive and sugar fermenting, but in immune deficient people the yeast
overgrows. For the yeast to be invasive, it alters its form to the mycelium
fungal stage, by producing rhizoids (long root-like structures) that are invasive
and able to penetrate the intestine mucousal barriers, releasing metabolic
toxins, and incompletely digested proteins into the blood stream (PRASAD,
1991; CHAITOW, 1996). This process initiates a series of adverse reactions
that may cause tissue damage, and a wide range of problems, including food
sensitivities or allergies (PRASAD, 1991).
Research indicates that many of the toxic effects observed with Candida
infection results from its ability to manufacture acetaldehyde, under
appropriate conditions, produced by both the clinical and laboratory
characteristics of the candidal infection (CHAITOW, 1996).
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Clinically the fungal infection is identified as "creamy-white, curd-like patches
on the tongue or other oral mucousal surfaces which are removed by
scrapings (DROUHET AND DUPONT, 1989). Progress to more severe
oesophageal candidiasis is associated with difficulty in swallowing and hence
causes dehydration, non-compliance with medication regimes and general
malnutrition (CLARK AND HUFFORD, 1993), which is sometimes associated
with severe diarrhoea (DROUHET AND DUPONT, 1989; DUBE AND
MUTLOANE, 2001). Hence, those who suffer from oral candidiasis often lose
a lot of weight due to a sore throat, which prevents them from eating (SANNE,
2001 ).
The presence of C. albicans is confirmed by positive KOH preparations or
Gram strains (negative and positive), which shows masses of hyphae,
pseudohyphae and yeast forms with positive culture (DROUHET AND
DUPONT, 1989).
The infection causes lesions in a wide variety of morphological sites: mouth,
bronchi, lungs, intestines, skin and vagina. It is most easily observed on the
mouth and oesophagus. The distribution of candidiasis lesions associated
with HIV infections is primarily a reflection of the specific alteration of host
immune responses endangered by the virus (ODDS et al., 1990).
Immunosuppression and long-term treatment with antifungal agents
associated with HIV infection cr~ate selective pressures (resistance) (ODDS
et al., 1990). Commencement of AIDS leads to increased use of antifungal
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agents, with some of the infected patients requiring therapy for life. Most
patients with symptomatic HIV infections or AIDS require long-term antifungal
therapy either as treatment or as prophylaxis of oral and oesophageal thrush
(FAN-HAVARD et al., 1991).
The emergence of bacterial resistance in patients after prolonged use of
antibiotics is well known and inevitable. The use of broad-spectrum antibiotics
alters the normal bacterial flora and allows the more resistant bacteria to
colonize (FAN-HAVARD et al., 1991). Candida and other infections deplete
the immune system. Treatment of these infections in an early stage can
therefore help reduce the deterioration in the health of an individual (SANNE,
2001 ).
2.3 Existing Anticandidal Drugs
The selection of anticandidal drugs is based on their selective toxicity towards
the fungal pathogen. The toxicity in turn depends on the cellular constituents
and their biosynthetic pathways in the pathogen (BORLARD, 1991).
There has been extensive research on the development of antifungal drugs,
but only six of these antifungal agents were licensed in 1995. These include
polyene amphotericin B, the azoles, imiazoles, miconazole and ketoconazole,
triazole and itraconazole and the pyrimidine synthesis inhibitor flucytosine (5-
Fe) (ESPINEL-INGROFF AND PFALLER, 1995).
Chapter 2 Candida albicans review 14
Polyenes act by binding to ergosterol in the fungal cell membrane, causing
osmotic instability and loss of membrane integrity. The azoles on the other
hand inhibit fungal cytochrome P450-dependent enzymes, with resulting
impairment of ergosterol synthesis and depletion of ergosterol in the fungal
cell membrane (ESPINEL-INGROFF AND PFALLER, 1995). Fluconazole is a
water-soluble, bifluorinated triazole, with low binding affinity for plasma
protein. It distributes extensively throughout the body, and readily diffuses into
saliva. This drug is highly successful in the treatment of AIDS patients whom
had relapsed after amphotericin Band flucytosine (5-FC) treatment
(DROUHET AND DUPONT, 1989).
The United States documented that nearly 10% of nosocomial bloodstream
infections are due to Candida albicans. Despite the treatment with fluconazole
and amphotericin B, the mortality associated with systemic C. albicans
infections is ~50% (LOUIE et al., 1995).
However, it has been found that the treatment with these drugs, especially for
extended periods of time, can lead to problems with toxicity to the patients
(amphotericin B) or lead to the development of resistant fungal organisms
during the course of therapy (5-fluorocystine) (BOONCHIRD AND FLEGEL,
1982). Since the incidence of these infections is on the increase, attempts are
being made to develop new chemotherapeutic agents or a combination of
agents to treat the fungus.
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Amphotericin B induces several dose dependent effects on the growth of C.
albicans in vitro:
• An increase in number of colony-forming units occurs at very low
doses, although the exact dose may vary depending on the
experimental conditions, this stimulatory effect has been seen in yeast
treated with 0.01-0.04 IJgmr1 . It also shows that at sub-inhibitory doses,
amphotericin induces chemical modification of the cell wall and
plasmamembrane of C. albicans.
• Inhibition of growth and germ-tube formation occurs at intermediate
concentrations (0.02-0.10 IJgmr\
• At higher concentrations (>0.30 IJg mr\ amphotericin B is lethal to C.
albicans cells. Here amphotericin-induced oxidative damage as the
mechanism of cell killing had been suggested (BORLARD, 1991).
Due to the sterol binding action of amphotericin B in the fungal cell
membrane, renal damage is found to occur in more than 80% of patients and
can be permanent in patients receiving larger doses of the drug (CLARK AND
HUFFORD, 1993). Flucytosine in combination with amphotericin B is
designed to reduce the dosage of amphotericin (thereby reducing its dose-
related toxicity) and to eliminate the development of resistance to flucytosine.
However, it has been noted that flucytosine toxicity may increase when it is
used in combination with amphotericin B (CLARK AND HUFFORD, 1993).
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Fluconazole costs the South African consumer R57 per 200 mg capsule, while
the public sector price is R36.33 for a 150 mg capsule. In pharmacies the
retail price is R80 per 200 mg tablet, this information therefore emphasizes
the non-affordability of the drug to the public sector at a cost of R20 000 per
person a year. At these prices the private sector, medical aid and patients
quickly exhaust their annual drug limits and become state patients (OUSE
AND MUTLOANE, 2001). This drug is made available free of charge to South
African patients for a period of two years and from then on will only be
available to patients with severe oesophageal infection. This initiative was put
into place in order to make the drug available to the poorest people in the
developing world. However, this is the only form of medication available for
free and none of the others are available at a cheap price. Candida is now
resistant to nystatin, gliotoxin, comirin, candicidin, pimaricin, filipin (filimarisin)
and triamicinolone acetonide (TA) in some form or another (SALTARELLI,
1989). Hence as most of the antibiotic medication on the market, the fungi
develop resistance against fluconazole.
The most intensive efforts to develop new antifungal agents have centred on
the synthesis of analogs of the existing azole antifungal agents. Features
related to biological or therapeutic effects are due to skeletal structures, which
tend to remain consistent throughout the class. This therefore means various
azole analogs may exhibit varying degrees of affinity and selectivity for the
molecular target, the fundamental mechanism remaining the same (CLARK
AND HUFFORD, 1993).
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Azoles' are fungistatic in their action requiring long-term (lifetime) use.
Therefore modifying the structure of existing agents to produce new products
is pointless as similar toxicity or resistance problems may recur (CLARK AND
HUFFORD, 1993). It is therefore clear that novel antibiotics can serve two
important functions:
a) As leads for production of novel agents; and
b) As probes for new molecular targets.
Searching for new prototypes of bioactive substances through natural
products is more advantageous than chemical synthesis or modification of
existing agents due to the likelihood of identifying novel prototype, drugs with
unique and different chemical structures and hence less similar toxicities,
cross resistance and mechanism of action (CLARK AND HUFFORD, 1993).
2.4 Plants with Activity against Candida albicans
The ongoing threat of synthetic agent resistance to yeast infections has led to
researchers concentrating on naturally acquired agents. A variety of
substances in food are known to act as antifungal or antimycotic agents. It
was discovered long before the existence of refrigerators that antimicrobial
properties of culinary herbs and spices could retard food spoilage (STILES et
al., 1995). Research has now focused on the ability of aromatic leaves,
essential oils and their active principals to inhibit fungal infections.
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Many researchers in the world have investigated antifungal properties,
involving the screening of plants against Candida albicans. Numerous species
from different plant families were tested and on the basis of their use in
traditional medicine, arrays of plants have been screened. Plants are a logical
choice chiefly because of their infinite variety of novel organic molecules.
Compounds, which possess novel mechanisms of action regardless of
whether they become clinically useful, and may serve as important
biochemical tools to probe the critical biochemical pathways of the
opportunistic pathogens (CLARK AND HUFFORD, 1993).
Many South African medicinal plants have been screened for antimicrobial
and antibacterial activity, but there has been few researchers working on the
anticandidal activity of the medicinal plants in South Africa Eclipa prosta is
highly active against Candida, due to the presence of a polyacetylene isolated
from the leaves. Bidens pilosa on the other hand contains an active
compound phenyllheptatriyene in the leaf and root infusions (VAN WYK et al.,
1997).
Caceres et al. (1991), Quiroga et al. (2001) and Agarwal et al. (2000) are
some of the recent researchers who have associated the antifungal activity of
most plants with secondary metabolites, which plants produce. These
metabolites include flavonoids, phenols, phenolic glycosides, lactones and
saponins. Agarwal et al. (2000) also reported on the antifungal and
antibacterial activity of anthraquinone derivatives. These derivatives include
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rhein, physcoin, aloe-emodin and chrysophanol, methanolic extracts from
dried rhizomes containing the active constituents. Eugenol and vanillin are
major constituents of clove oil and vanilla respectively, and both these
compoundsare highly active against Candida (BOONCHIRD AND FLEGEL,
1982).
The fruit of Solanum incanum, a weed found in Tanzania and Kenya is
extensively used for the treatment of cutaneous mycotic infections and other
pathological conditions and are highly active against Candida. This is due to
the presence of solanine, a glycoalkaloid (SAWHNEY et al., 1978). In
addition to the three known polyenes from Devil's club (Oplopanax horridus) ,
Kobaisy et al., (1997) isolated two more polyenes that exhibited anticandidal,
antibacterial and antimycobacterial activity. Oregano, cloves, garlic, onions,
thyme and savory are but a few of 44 herbs and spices found to inhibit the
growth of C. albicans and other potentially pathogenic bacteria (STILES et al.,
1995). Table 2.4.1 lists different plants with anticandidal activity and activity
against other microorganisms.
Table 2.4.1 Plants with anticandidal activity




Achyranthes aspera AMARATHACEAE Flower Sa, PI Ethiopia DESTA,1993 I N0
III




Asplenium trichomanes ASPlENIACEAE Root Sa; Ec; Pv; Pa Ethiopia DESTA, 1993 I III0=
Aspilia africana
o'
ASTERACEAE leaf and root Bs; Ms Rwanda SOllY and VAN PUYVElDE, 1986 I III::J
C/)
.....
Berberis ho/sW SERSERIDACEAE Root bark Ba, Ms Ethiopia DESTA, 1993 I CD<(D'
Berchemia discolor RHAMNACEAE leaf Sa; Ec; Pv; Pa Ethiopia DESTA,1993
:::
Bidens borneana COMPOSITAE Flower Sa, Sg Ethiopia DESTA, 1993
Bidens pilosa ASTERACEAE leaf Bs; Ms; Sa; Sg Rwanda SOilY and VAN PUYVElDE, 1986
Cajanus cajan FASACEAE leaf Bs; Ms; Sa Rwanda SOilY and VAN PUYVElDE, 1986
Coleus kilimandschari LAMlACEAE Stem and root Bs; Ms; Sa Rwanda SOllY and VAN PUYVElDE, 1986
Dafbergia lactea FASACEAE Root Ms; Sa Rwanda SOllY and VAN PUYVElDE, 1986
Dryopteris inaequalis ASPIDICEAE Rhizomes Bs; Ms; Sa Rwanda SOllY and VAN PUYVElDE, 1986
Gynandropsis gynadra CAPPARIDACEAE leaf Ms Rwanda SOilY and VAN PUYVElDE, 1986









Iboza riparia LAMIACEAE leaf as; Ms; Sa Rwanda BOllY and VAN PUYVElDE, 1986 CD....,
N





Mitragyna rubrostipulata RUBIACEAE Stem Ms; Sa Rwanda BOllY and VAN PUYVElDE, 1986 I 0=C'i"
Q)
:J







Monechma subsessile ACANTHACEAE leaf as; Sa Rwanda BOllY and VAN PUYVElDE,1986
Rhus vulguris ANACARDIACEAE Bark of roots as; Ms; Sa Rwanda BOllY and VAN PUYVElDE, 1986
Rumex abyssinicus POlYGONACEAE Root Ss; Ms; Sa Rwanda BOllY and VAN PUYVElDE, 1986
Rumex usambarensis POlYGONACEAE leaf Ss; Ms; Sa Rwanda BOilY and VAN PUYVElDE, 1986
Schinus molle ANACARDIACEAE Whole plant Fo; Pn; An & T Argentina QUIROGA, et al., 2001
Schizozygia coffaeoides APOCYNACEAE leaf Tm; Mg; Cc Kenya KARIBA, et al., 2001
Withania somnifera SOLANACEAE leaf Ss; Ms; Sa Rwanda BOllY and VAN PUYVElDE, 1986
Sa- Stapylococcus aerus, Sg- Salmonella gaffinarum, Pa- Pseudomonas aeruginosa, Ms- Mycobacterium smegmatis, Bs- Bacillus subtilis, Mg-
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2.5 Aims and Objectives of this Study
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This project was aimed at:
• Identifying plants used by traditional healers to treat oral thrush;
• Establishment of an anticandidal bioassay;
• Screening of plant material for anticandidal activity, in order to identify
the most active plants;
• Assess extract stability in solution; and
• Develop a fingerprinting system for quality control.
CHAPTER 3
SCREENING OF MEDICINAL PLANTS FOR ANTICANDIDAL
ACTIVITY
3.1 INTRODUCTION
Plant derived natural products have long been, and will continue to be,
extremely important as sources of medicinal agents and models for the
design, synthesis and semisynthesis of novel substances for treating human
diseases (BALANDRIN et al., 1993). The goals of using plants as sources of
therapeutic agents are; a) isolation of bioactive compounds for direct use as
drugs; b) to produce bioactive compounds of novel and known structures as
lead compounds for semisynthesis of entities with higher activity and/or lower
toxicity; c) to use agents as pharmacological tools; and d) to use the whole
plant or part of the plants as herbal remedy (FABRICANT AND
FARNSWORTH,2001).
Screening of South African medicinal plants for antifungal activity will be
beneficial, in providing an alternative medication and availing cheap, easy to
prepare medication. These benefits are aimed at the community level where
medicinal plants are extensively used in primary health care. Plants with the
best anticandidal activity will be identified using the MIC assay.
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3.2 MATERIALS AND METHODS
3.2.1 Plant material
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Plant material was selected according to their use by traditional healers and
literature reports on their biological activity as anticandidal, antifungal and
antibacterial agents. All plant parts were dried in an oven at 50°C for two
days. The material was then ground to fine powders and stored in airtight
containers at room temperature. The plants investigated are listed in Table
3.2.1.














Bidens pilosa L. Asteraceae leaves 8 MOTSEI24 UN JAGER et al., 1996 I
(0
0-.





Bulbine frutescens (L.) Willd Asphodelaceae leaves 1 MOTSEI23 UN WATT & BREYER- BRANDWIJK, 1962 ::J
~
"0
Bulbine natalensis Wolf Asphodelaceae leaves 1 MOTSEI5 UN VAN WYK et al., 1997 Ol::J--(J)












Erythrina Iysistemon Hutch. Fabaceae bark, leaves 1 MOTSEI12 UN HUTCHINGS et al., 1996 I Ol0--<'
Eucomis autumnalis L' Her I
;:::0:
Hyacinthaceae bulbs 2 MOTSEI14 UN VAN WYK et al., 1997 "<
Glycyrrhiza glabra L. Fabaceae rhizomes 7 VAN WYK et al., 1997
Haemanthus albiflos Jacq. Amaryllidaceae bulbs, leaves 1 MOTSEI9 UN HUTCHINGS et al., 1996
Hypoxis hemerocallidea Hypoxidaceae corms 2 MOTSEI4 UN VAN WYK et al., 1997
N
(Fisch. & Mey.) CJ1






Plumbago auriculata Lam Plumbaginaceae leaves 2 MOTSEI7 UN HUTCHINGS et al., 1996 I wC/)
0-.
Polygala myrtifolia L. Polygalaceae leaves 2 MOTSEI17 UN WATT & BREYER- BRANDWIJK, 1962 I Cl>Cl>
:::l
:::l
Rubus rigidus J.E. Sm. Roseaceae leaves 5 MOTSEI 11 UN WATT & BREYER- BRANDWIJK, 1962 I to0
-+0










Tagetes minuta L. Asteraceae leaves 8 MOTSEI 25 UN BII et al., 2000 "'0
tu
:::l......
Trichilia emetica Vahl. Meliaceae bark, leaves 2 MOTSEI 26 UN BRUNETON, 1995 I Ul-+0
0-.










Warburgia salutaris Engl. Canellaceae leaves 2,3 MOTSEI15 UN VAN WYK et al., 1997 -tu
0......




Zanthoxylum capense Rutaceae leaves 1 MOTSEI10 UN HUTCHINGS et al., 1996
Thunb.Harvey
1-Pietermaritzburg National Botanical Garden; 2- University of Natal Botanical Garden; 3- Silverglen Nature reserve; 4- Vallea-Vista
Nursery; 5- Drakensberg; 6- KZN South Coast; 7- Health shop and 8- Grassland field University of Natal Nen
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3.2.2 Preparation of extracts
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One gram of powdered plant material was weighed out and placed into a pill vial
to which 10 ml of either ethanol, ethyl acetate, hexane or water was respectively
added. The material was extracted in an ultrasound bath for 1 hour, and then
allowed to stand for 30 minutes before being filtered using Whatman No. 1 filter
paper in Buchner funnels. The extracts were dried in front of a desk fan.
3.2.3 Candida albicans strains and their maintenance
Three Candida strains were used. Two clinical isolates were prepared from
hospital patients (a 5-month-old baby and an adult). A standard strain ATCC
10231 was obtained from SABS (South African Bureau of Standards). Scrapings
of the clinical isolates were maintained on Sabouraud dextrose agar plates whilst
the standard strain was maintained on YM (Yeast Mould) media agar plates. All
the plates were kept in the fridge and subcultured every three to four weeks
(ESPINELL-INGROFF AND PFALLER, 1995).
3.2.4 Screening ofplant material
The water extract residues where dissolved in water and organic solvent extracts
residues where dissolved in DMSO (Dimethyl sulfoxide). All extracts where
dissolved to a concentration of 100 mgmr1. All extracts were tested in triplicates.
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3.2.5 Antifungal assay
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A modification of the NCCLS proposed method (M27-P) broth microdilution test
(ESPINELL-INGROFF AND PFALLER, 1995) was performed as follows: Four
millilitres of sterile saline were added to 400 1-11 of 24 hr old Candida cultures.
The absorbance was read at 530 nm and adjusted with sterile saline to match
that of a 0.5 McFarland standard solution (Appendix 1). From the prepared stock
yeast culture a 1:1000 dilution with broth (e.g. 10 1-11 stock yeast culture: 10 ml
broth) was prepared.
One hundred 1-11 of broth were added to each of a 96-well microplate. One
hundred 1-11 of the water extracts were added into well (A) and serially diluted from
(A) by taking 100 1-11 into (B). This two-fold dilution was continued down the plate
and a 100 1-11 from the last well (H) were discarded. In the case of organic
solvents extracts 25 1-11 of the organic solvent extracts were added to 175 1-11 broth
and serially diluted. Three replicates were prepared for each extract. All the wells
were then filled with 100 1-11 of stock yeast culture. Amphotericin B was used as a
standard for this experiment and the following controls were prepared: wells
containing broth only; the different strains of fungi with no extract, and a serial
dilution of the amphotericin B with the fungi at the recommended inhibitory
concentrations. The plates were then read at 630 nm in an ELlSA reader,
covered with parafilm and incubated at 33°C overnight, whereafter their
absorbance was reread.
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3.3 RESULTS AND DISCUSSION
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The results of anticandidal activity are presented in Table 3.3A and 3.3B. A
number of plants exhibited activity against the Candida albicans strains used,
with clear indications that the strain from the 5-month-old strain was the most
susceptible, followed by the strain from an adult strain and lastly the standard
strain, which was found to be resistant to most plant extracts screened.
Aqueous extracts of A. sativum, G. glabra, P. myrtifolia and T. violacea had the
best activity amongst all the plants screened (Table 3.3A). A. sativum showed
the best activity amongst the four extracts. It had an MIC value of 0.56 mgmr1
with the strain from a 5-month-old baby and 6.25 mgmr1 for both the strain from
an adult and standard (ATCC 10231) strain. Garlic is one of the most popular
used herbal alternative therapies, with over 300 varieties of garlic grown all over
the world (MORBIDONI et al., 2001). Garlic has for many years being used to
treat arthritis, asthma, toothache, cancer, cardiovascular diseases and many
other ailments (MORBIDONI et al., 2001). Certain extracts of garlic are
antibacterial, antifungal, antiviral and antithrombotic (YOSHIDA et al., 1987;
MORBIDINI et al., 2001). Aqueous extracts from the bulb have been used in the
past to control several human diseases, such as snakebites, haemorrhoids,
rheumatism, abdominal pains and skin infections (SINGH et aI., 1990). In
humans, antifungal activity was detected in serum after ingestion of garlic
(YOSHIDA et al., 1987).
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The bulbs of Tulbaghia violacea showed activity with MIC values of 3.25 mgmr1
for the clinical isolate from the 5-month-old baby, 6.25 mg mr1 for the isolate from
an adult and 12.5 mgmr1 for the standard strain (ATCC 10231). It should be
noted that the leaves of T. violacea were also screened, but no activity against
any of the strains test strains was detected. T. violacea also known as wild garlic
is a bulbous plant with long, narrow, hairless leaves arising from several white,
fleshy bases. All parts of the plant have a strong smell of garlic when damaged,
hence the common name. It has attractive mauve or pale purple flowers, which
occur in groups at the tip of a slender stalk (VAN WYK et al., 1997). This bulbous
plant is traditionally used for fever and colds, but also for asthma and
tuberculosis (WATT AND BREYER-BRANDWIJK, 1962). Decoctions are
administered as enemas for stomach problems and the leaves are used to treat
cancer of the oesophagus (WATT AND BREYER-BRANDWIJK, 1962;
HUTCHINGS, 1996).
MIC values for Glycyrrhiza glabra rhizomes were 1.56 mgml-1 for the isolate from
a 5-month-old baby isolate and 12.5 mgmr1 for both the isolate from an adult and
the standard (ATCC 10231) strain. Liquorice, as G. glabra is commonly known
belongs to the family Leguminosae. It is a robust perennial herb up to one metre
in height, with a multi-branched, underground rhizome and an erect woody stem.
The rhizomes, which are mostly referred to as roots, are harvested for medicinal
and other uses such as flavouring of food products (VAN WYK et al., 1997). Its
main use is to sweeten decoctions, to mitigate the actions of drastic drugs and to
relieve pain caused by muscle contraction (HIKINO, 1985). The dried rhizome or
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extracts thereof are used to treat ulcers and coughs. In the Western Cape, South
Africa it has been an early remedy for appendicitis and tuberculosis (WATT AND
BREYER-BRANDWIJK, 1962; VAN WYK eta!., 1997). In European countries it is
used as a corrective, an expectorant, an antitussive and an antiulcer agent
(HIKING, 1985).
Polygala myrtifolia also showed a strong inhibition against the isolate from the 5-
month-old baby with an MIC value of 3.25 mgml,l and MIC values of 6.25 mgml'l
for both the isolate from an adult and the standard (ATCC 10231) strain. P.
myrtifolia is an evergreen small tree of up to 4 m in height, with a dense crown.
The leaves are soft and light green with rounded tip endings. The flowers form in
short clusters at the tips of the branches. It is distributed from Zululand in the
north to the Western Cape in the south of South Africa. This plant occurs in
forests, scrubveld and wooded grasslands (VENTER AND VENTER, 1996). The
leaves are used in poultices for gout. Aqueous extracts of the green parts of this
plant tested negative with S. aureus (WATT AND BREYER-BRANDWIJK, 1962).
Amongst the organic solvent extracts tested, Bidens pilosa (ethanol), Dodonaea
angustifolia (ethanol and ethyl acetate), G. glabra (ethanol and ethyl acetate), P.
myrtifolia (ethanol), Leonotis leonurus, Siphonochilus aethiopicus (ethanol, ethyl
acetate and hexane), Tagetes minuta (ethanol) and T. violacea (ethanol and
ethyl acetate) extracts were active against all Candida strains (Table 3.3B).
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Table 3.3A Minimum inhibitory concentration of aqueous extracts against
Candida albicans clinical isolates from a 5-month-old baby, an adult, and
I
the standard strain (ATCC 10231)
MIC (mgmr1)
Plant Part 5-month-old Adult ATCC
baby 10231
Allium sativum bulbs 0.56 6.25 6.25
Bidens pilosa leaves 25 25 25
Brachanellia hulleensis leaves >25 >25 >25
Bulbine frutescens leaves >25 >25 >25
Carpobrotus edulis leaves >25 >25 >25
Oodonaea angustifolia leaves >25 >25 >25
Erythrina Iysistemon bark 25 >25 25
leaves 25 >25 >25
Eucomis autumnalis bulbs >25 >25 >25
Glycyrrhiza glabra rhizomes 1.56 12.5 12.5
Haemanthus albiflos bulbs >25 >25 >25
leaves >25 >25 >25
Hypoxis hemerocallidea corms >25 >25 >25
Jatropha curcas leaves 25 25 25
Leonotis leonurus leaves 12.5 >25 >25
Polyga/a myrtifolia leaves 1.56 6.25 6.25
Plumbago auriculata leaves >25 >25 >25
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Rubus rigidus leaves >25 >25 >25
stem 12.5 >25 25
Siphonochilus aethiopicus bulbs >25 >25 >25
Tagetes minuta leaves 25 25 25
Trichilia emetica leaves >25 >25 >25
bark 6.25 25 25
Tulbaghia violacea bark 3.25 6.25 12.5
leaves >25 >25 >25
Vertiveria zizaniodes leaves 25 25 12.5
Warburgia salutaris bark 6.25 12.5 12.5
leaves 1 >25 >25 >25
leaves 2 12.5 12.5 25
Zantedeschia aethiopica leaves >25 >25 >25
Zanthoxylum capense bark >25 >25 >25
1-University of Natal Botanical garden collection, 2- Silverglen collection.
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Table 3.38 Minimum inhibitory concentration of organic solvent extracts
against Candida albicans clinical isolates from a 5-month-old baby and an
adult, and standard strain (ATCC 10231)




Bidens pilosa leaves EtOH 2.09 2.09 2.09
EtOAc 8.35 8.35 8.35
Hex >8.35 >8.35 >8.35
Brachanellia leaves EtOH >8.35 >8.35 >8.35
hulleensis EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Bulbine frutescens leaves EtOH >8.35 >8.35 >8.35
EtOAc 2.09 8.35 8.35
Hex >8.35 >8.35 >8.35
Carpobrotus edulis leaves EtOH >8.35 >8.35 >8.35
EtOAc 2.09 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Oodonaea leaves & EtOH 2.09 2.09 2.09
angustifolia twigs EtOAc 1.04 1.04 2.09
Hex >8.35 >8.35 >8.35
Erythrina bark EtOAc 8.35 8.35 8.35
Iysistemon EtOH 8.35 8.35 8.35
Hex >8.35 >8.35 >8.35
leaves EtOH 8.35 >8.35 >8.35
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EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Eucomis bulbs EtOH >8.35 >8.35 >8.35
autumnalis EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Glycyrrhiza glabra rhizomes EtOH 0.52 2.09 2.09
EtOAc 2.09 1.03 2.09
Hex >8.35 >8.35 >8.35
Haemanthus bulbs EtOH 8.35 >8.35 >8.35
albiflos EtOAc 8.35 >8.35 >8.35
Hex 8.35 >8.35 >8.35
leaves EtOH 2.09 8.35 8.35
EtOAc 2.09 8.35 8.35
Hex >8.35 >8.35 >8.35
Hypoxis corms EtOH >8.35 >8.35 >8.35
hemerocallidea EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Jatropha curcas leaves EtOH 8.35 8.35 8.35
EtOAc 8.35 8.35 8.35
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EtOAc 8.35 8.35 >8.35
Hex >8.35 >8.35 >8.35
Plumbago leaves EtOH >8.35 >8.35 >8.35
auriculata EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Rubus rigidus stem EtOH >8.35 >8.35 >8.35
EtOAc 8.35 8.35 8.35
Hex >8.35 >8.35 >8.35
Leaves EtOH >8.35 >8.35 >8.35
EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Siphonochilus bulbs EtOH 1.03 1.03 2.09
aethiopicus EtOAc 1.03 1.03 2.09
Hex 1.03 1.03 2.09
Tagetes minuta leaves EtOH 2.09 2.09 4.18
EtOAc 8.35 8.35 8.35
Hex >8.35 >8.35 >8.35
Trichilia emetica bark EtOH >8.35 >8.35 >8.35
EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
leaves EtOH >8.35 >8.35 >8.35
EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Tulbaghia vio/acea bulbs EtOH 0.26 2.09 2.09
EtOAc 0.13 2.09 2.09
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Hex 8.35 8.35 8.35
leaves EtOH >8.35 >8.35 >8.35
EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Vertiveria leaves EtOH >8.35 >8.35 >8.35
zizaniodes EtOAc 8.35 8.35 8.35
Hex >8.35 >8.35 >8.35
Warburgia bark EtOH 4.18 8.35 8.35
salutaris EtOAc 8.35 8.35 8.35
Hex 4.18 4.18 4.18
leaves 1 EtOH >8.35 >8.35 >8.35
EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
leaves 2 EtOH 8.35 8.35 8.35
EtOAc 8.35 8.35 8.35
Hex 4.18 4.18 4.18
Zantedeschia leaves EtOH >8.35 >8.35 >8.35
aethiopica EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Zanthoxylum leaves EtOH >8.35 >8.35 >8.35
capense EtOAc >8.35 >8.35 >8.35
Hex >8.35 >8.35 >8.35
Amphotericin 8 (standard) 1.56-3 >8.35 >8.35
EtOH- ethanol, EtOAc- ethyl acetate, Hex- Hexane
1-University of Natal Botanical garden collection, 2- Silverglen collection.
CHAPTER 4
FINGERPRINTING OF ACTIVE PLANT EXTRACTS
4.1 INTRODUCTION
Thin layer chromatography (TLC) is the most widely used of all the simple
chromatographic methods for analysis of plant extracts (WAGNER et al.,
1984). This is due to its rapidity and ease of visual evaluation, and has
become the most ideal analytical method for plant drugs and preparations that
contain drug extracts or pure constituents. Advantages of this method include
the short time required for the detection of characteristic constituents of a
drug. TLC also provides semi-quantitative information on the chief active
constituents of a drug, thus enabling an assessment of drug quality, in
addition to its qualitative detection (WAGNER et al., 1984). It is suitable for the
monitoring of identity and purity of drugs against adulteration and substitution,
as it provides a chromatographic drug fingerprint, and can also be used to
analyse drug combinations and phytochemical preparations (WAGNER et al.,
1984).
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4.2 MATERIAL AND METHODS
4.2.1 Plant material
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All the plant material, which showed activity with the water, ethanol, ethyl
acetate and hexane extracts were chosen for fingerprinting.
4.2.2 Extraction ofplant material
Plant material was dried in an oven at 50°C and subsequently finely ground
and stored at room temperature in glass bottles. One hundred grams of
ground material were extracted with 10 ml of water or organic solvents in an
ultrasound bath for one hour and left to stand for 30 minutes. The extracts
were filtered using Whatman No. 1 filter paper and taken to dryness in front of
a desk fan. The residues were diluted in water and organic solvents to a
concentration of 50 mgmr1.
Fresh bulb extracts of Allium sativum and Tulbaghia violacea were prepared
using 10 g of garlic cloves and T. violacea bulbs; these were blended with 50
ml water, ethanol, ethyl acetate, hexane and dichloromethane respectively.
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4.2.3 Fingerprinting
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Five hundred IJg of water, ethanol, ethyl acetate and hexane extracts of
selected plants were applied to glass backed silica gel plates (1 Ox1 0 cm, 0.25
mm) for fingerprinting. The extracts were loaded as one cm bands and the
plates were developed in suitable solvent systems. Table 4.2.1 summarizes
the solvent systems used with the different plant extracts. The TLC plates
were removed from the tank and allowed to dry. The bands were viewed
under UV-light (254 nm and 366 nm) and photographed for reference.
Table 4.2.1 Solvent systems used for the fingerprinting of screened plant
extracts
Plant extract Solvent system Ratios (v/v)
Allium sativum Toluene: ethyl acetate 100:30
Glycyrrhiza glabra Toluene: ethyl acetate 100:30
Polyga/a myrtifolia Toluene: ethyl acetate 100:30
Tulbaghia violacea Toluene: ethyl acetate 100:30
Siphonochilus aethiopicus Hexane: ethyl acetate 2:1
Leonotis leonurus Hexane: ethyl acetate 2:1
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4.2.4 Bioautography
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All the above TLC plates were run in duplicate. The plates were developed
and allowed to stand overnight, as this allowed the solvents to evaporate. The
bioautographic assay was carried out using the fungal strain ATCC 10231.
Ten ml of the overnight culture were prepared. The cultures were mixed with
50 ml YM broth and placed in a dip tank. The developed TLC plates were then
dipped in the tank and placed on damp paper towels in a metal tray. The trays
were covered with cling wrap, and incubated in an oven at 33°C overnight or
until growth was observed. To detect the antifungal activity on the plates, they
were sprayed with INT (p-iodonitrotetrazolium-violet, Sigma) prepared at two
mgmr1. Five ml of the INT was sprayed onto the plates. Positive results are
observed when clear white areas appear on the red background due to the
reduction of INT by the fungi.
4.3 RESULTS AND DISCUSSION
Figure 4.3.1 illustrates the TLC chromatogram of Allium sativum viewed under
UV254 nm; the bands were a distinct blue-green for all prepared extracts,
varying in number of bands depending on the extracting solvent. The TLC
chromatogram of Tulbaghia violacea yielded two visible bands each for the
ethanol and ethyl acetate extracts viewed under UV254 nm (Figure 4.3.2), The
dichloromethane and hexane extracts did not separate out into visible bands.
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Hex EtOAc EtOH DiChl
Figure 4.3.1 TLC chromatogram of Allium sativum extracts viewed
under UV light (A) 254 nm. EtOH-ethanol; EtOAc-ethyl acetate; Hex-
hexane; DiChl- dichloromethane.
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EtOH EtOAc Hex DiChl
Figure 4.3.2 TLC chromatogram of Tulbaghia vio/acea extracts
viewed under UV light 254 nm. EtOH-ethanol; EtOAc-ethyl
acetate; Hex-hexane; DiChl- dichloromethane.
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Palladium chloride is a stain specially used to detect allicin, which stains a
brown-red colour (WAGNER, 1996). Allicin can be clearly identified on both
the TLC chromatograms of A. sativum and T. violacea stained with this
reagent (Figure 4.3.3A and Figure 4.3.4A) respectively. Allicin is one active
principle of freshly crushed garlic homogenates. This main active constituent
of garlic was isolated and identified in 1944. It is formed only when garlic
gloves are minced or crushed as a result of enzyme action of its constituents
(YAMADA AND AZUMA, 1977; HUGHES AND LAWSON, 1991). Allicin is an
oxygenated sulphur compound, which is volatile and poorly miscible in
aqueous solutions (ANKRI AND MIRELMAN, 1999). In pure form allicin
exhibits antibacterial activity against a wide range of Gram-positive and Gram-
negative bacteria, including multi-drug-resistant entertoxicogenic strains of
Escherichial coli; antifungal activity against Candida albicans; antiparisitic
activity against some major human intestinal protozoans such as Entamoeba
histolytica and Giardia lamblia; and also antiviral activity (ANKRI AND
MIRELMAN, 1999).
Garlic extracts have strong antifungal effects; they inhibit the formation of
mycotoxins like the aflatoxins of Aspergillus parasiticus. Allicin is the major
component responsible for the inhibition of fungal growth, 34 % of concentrate
garlic extracts is allicin and the remaining 44 % and 20 % comprising of
thiosulfinates and vinyldinthiins respectively (ANKRI AND MIRELMAN, 1999).
Garlic has also been used successfully in preventing and treating
experimental infections with Candida albicans in chickens. Activity has also
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been reported in human serum against seven species of Candida and two
species of Cryptococcus (HUGHES AND LAWSON, 1991). Allicin is thought
to disrupt cellular metabolism primarily by oxidation of essential thiols to the
corresponding disulphide by the liable oxygen of allicin, thereby inactivating
proteins. Another mechanism may be competitive inhibition of all sulphydryl
compounds at low concentration. Non-competitive mechanisms of inhibiting
enzymes of function, blockage of cellular lipid biosynthesis or decreasing fungi
virulence through enhancement of yeast to mycelial conversion may also
occur (RODE et al., 1989).
E/Z-ajoene is the only water-soluble transformation compound of allicin and a
minor component in oil-macerates of garlic and is known as a potent
antithrombotic (SINGH et al., 1990). This component also demonstrates
anticandidal activity, although its activity is found to be less than that of
thiosulphinates (YOSHIDA et al., 1987; HUGHES AND LAWSON, 1991).
E/Z-ajoene has also been found to inhibit spore germination of fungi, which
cause diseases in crop plants (SINGH et al., 1990). This compound however
was found not to elicit antibacterial activity against Gram-positive and Gram -
negative bacteria except for Staphylococcus aureus (YOSHIDA et al., 1987)
Burton and Kaye (1992) isolated two sulphur compounds from T. violacea. As
it is a general occurrence in the Alliaceae family and in Allium species, T.
violacea was found to contain low molecular mass sulphur compounds. The
two unidentified compounds in T. violacea therefore supported the modern
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classification, which includes Tulbaghia species in the Alliaceae family
(BURTON AND KAYE, 1992). The medical activity of sulphur compounds
such as the activity of allicin in garlic was well established and observed in the
bacteriostatic action of T. vio/acea extracts, and is attributed to the biologically
active sulphur compounds (BURTON AND KAYE, 1992).
Duplicates of the palladium stained plates of A. sativum and T. violacea
where prepared for bioautography, with Candida albicans (ATCC 10231)
culture overlay. The inhibition of C. albicans on these plates is clearly seen by
the contrast of white bands corresponding to separated bands of the extracts
on the red background of the plates (Figure 4.3.3B and Figure 4.3.4B)
respectively. The fungus uses INT as a terminal electron acceptor and is
reduced to a white colour where it had grown, the red background therefore
illustrating fungal growth. There are white bands on the INT stained plates,
which correspond allicin bands on the palladium chloride stained
chromatograms.





Hex EtOAc EtOH DiChl
Figure 4.3.3 TLC fingerprinting of solvent extracts of Allium sativum (A)
stained with palladium chloride. (B) Bioautographic plate with Candida
albicans (ATCC 10231) after staining with INT, white spots indicate
inhibition of fungal growth. Hex- hexane; EtOAc-ethyl acetate; EtOH-
ethanol; DiChl-dichloromethane.
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A
B
Hex EtOAc EtOH DiChl
Figure 4.3.4 TLC fingerprinting of solvent extracts of Tulbaghia violacea
(A) stained with palladium chloride. (B) Bioautographic plate with Candida
albicans (ATCC 10231) after staining with INT, white spots indicate
inhibition of fungal growth. Hex- hexane; EtOAc-ethyl acetate; EtOH-
ethanol; DiChl-dichloromethane.
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Glycyrrhiza glabra and Polygala myrtifolia are two other highly active plants,
which were prepared for fingerprinting and bioautography. The water extracts
of these two plants showed presence of saponins. Saponins were identified by
formation of foam in the preparation of the extracts. These compounds
constitute a vast group of glycosides, which are ubiquitous in plants. They are
characterized by their surface-active properties and they dissolve in water to
form foamy solutions. This surface activity is the reason why some drugs
containing saponins have been used for ages as household detergents. Some
saponins have haemolytic properties and are widely distributed in plants.
Their industrial applications include starting materials for the semi-synthesis of
steroidal drugs (BRUNETON, 1995). Other biological and pharmacological
properties of saponins in vivo are known to be the defence mechanism, which
plants have against fungal attack (BRUNETON, 1995). The activity against
fungi has been established against pathogenic species, as well as towards
various Candida species and dermatophytes. Their activity is attributed to
monodesmosides, which are thought to result from the reaction of the
saponins with the membrane sterols of the microorganism (BRUNETON,
1995). Saponaris officinalis is one plant, which has been widely used for its
biologically active saponins (BRUNETON, 1995).
TLC fingerprints of G. glabra and P. myrtifolia were prepared from the
aqueous extracts. Separation of the two water extracts is clearly seen in
(Figure 4.3.5A) viewed under UV254 nm. Although both of the extracts showed
characteristics of saponins the appearance to the bands showed that P.
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myrtifolia separated into pink compounds whilst G. glabra separated into blue
and white compounds. The same plate viewed at UV366 nm, also illustrates the
bands in different colours, with those of G. glabra appearing a blue-green
colour and those of P. myrtifolia appearing yellow-green colour and one major
blue compound (Figure 4.3.58).
G. glabra contains a variety of constituents, but its clinical effectiveness may
be exerted mainly by three groups of substances: saponins, flavonoids and
polysaccharides. Glycyrrhizin is one of the main components of liquorice root.
It consists of one molecule of glycyrrhetinic acid and two molecules of
glucuronic acid. The liquorice saponins consist of one major component,
glycyrrhizin (glycyrrhizin acid), and 13 minor components whose proportions
vary depending on the species and collecting location. Glycyrrhizin is
responsible for the liquorice-like sweetness and is 50 times sweeter than
sucrose. This main saponin is present in concentrations of 2%- 6% (VAN
WYK et al., 1997). This property accounts for the widespread use of this crude
drug in many composite prescriptions. It is thought that liquorice is effective
for sore throat due to its sweetness and the acceleration of tracheal mucous
secretion mediated by the saponin glycyrrhizin. This also explains its use as
an expectorant and antitussive (HIKING, 1985). Glycyrrhizin has anti-
inflammatory activity and also weak antiviral, antibacterial, antihepatoxic,
immunostimulating and healing activities (VAN WYK et al., 1997).
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Literature on the antibacterial and antifungal properties being identified in P.
myrtifolia is not available, but other species of Polygala are known for the
presence of antibacterial and antifungal compounds. A chromonocoumarin
derivative was isolated from Polygala fruticosa and found to have antifungal
activity (VAN WYK et al., 1997). Chesne et al. (1983) conducted a study on
the fungicidal activity of higher plants. Amongst the plants screened the aerial
parts of Polygala vulgaris showed the presence of alkaloids, phenolic acids,
flavonoids, tannins and saponins, but the fungicidal effect of the crude
extracts was attributed to saponins.
Highlanders of Malawi and bordering countries use Polygala nyikensis to treat
various skin diseases of fungal origin. Two antifungal xanthones were isolated
from Polygala nyikensis and are active against the plant pathogen
Cladosporium cucumerinum (MARSTON et al., 1993). Polygala senega is one
species, which has been highly studied. A drug has been developed form this
plant and is known to contain lipids, methyl salicylate, phenolic acids and 5%-
10 % saponins. The saponins present are glycoside of presenegin and the
chief constituents are bidesmoides, however, the drug is mostly used as a
treatment for coughs (BRUNETON, 1995).





Figure 4.3.5 TLC chromatogram of Glycyrrhiza glabra and
Polygala myrtifolia water extracts viewed under UV light (A)
254 nm; (8) 366 nm.
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Extracts of Leonotis leonurus, Siphonochilus aethiopicus are a few of the
organic solvent extracts, which showed activity. Figure 4.3.6A illustrates the
TLC plate of L. leonurus viewed under UV254 nm, here the bands appear blue-
green in colour with a distinct blue band which is similar in all three extracts.
Figure 4.3.6B on the other hand is a view of the same plate at UV366 nm , the
compounds separated into pink bands for the ethanolic extract and the ethyl
acetate extract whilst the hexane extracts showed bands separating into
white. From the TLC chromatograms of the above plant extracts it is clearly
seen that hexane is a poor solvent to use for extracting compounds as fewer
compounds were resolved. Antifungal activity has been established against
ethanolic extracts of Leonotis neptaefolia.




Figure 4.3.6 TLC chromatogram of Leonotis leonurus extracts
viewed under UV light (A) 254 nm; (B) 366 nm. EtOH-ethanol;
EtOAc-ethyl acetate; Hex-hexane.
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The TLC chromatogram of S. aethiopicus (Figure 4.3.7) shows separation of
compounds into blue and green bands viewed under UV366 nm. The ethanolic
and the ethyl acetate extracts showed identical band separation, whilst the
hexane extract showed separation of a few compounds, which also
corresponded to those of the other two extracts. Amongst other recorded
uses, S. aethiopicus underground parts are traditionally used for treatment of
asthma and dysmennorhoea (WATT AND BREYER-BRANDWIJK, 1962;
HUTCHINGS et al., 1996). Rhizomes have also been found to be
antibacterially active against numerous Gram-negative and Gram-positive
bacteria (ZSCHOCKE et al., 2000). Although the compounds responsible for
the antifungal properties have not been identified, they are assumed to be the
same ones responsible for the antibacterial activity.




Figure 4.3.7 TLC chromatogram of Siphonochilu5 aethiopicU5 extracts
viewed under UV light (A) 254 nm; (8) 366 nm. EtOH-ethanol; EtOAc-
ethyl acetate; Hex-hexane.
CHAPTER 5
STABILITY TESTING OF ACTIVE PLANT EXTRACTS
5.1 INTRODUCTION
For the clinical use of plant extracts for candidiasis, either in hospitals or for
home care, it is essential to know how long the extracts can be stored without
losing of activity. Since chemical breakdown is temperature dependant, it
would be necessary to take into consideration the storage condition in which
home care products would be kept under, especially during hot summer days.
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5.2 MATERIALS AND METHODS
5.2.1 Stability Testing
58
Stability tests were carried out on aqueous extracts of Allium sativum,
Glycyrrhiza glabra, Polyga/a myrtifolia and Tulbaghia vio/acea. The aqueous
extracts were prepared by diluting dried extracts to 100mg/ml. The diluted
extracts were divided into three parts and stored at 4°C, 23°C and 33°C
(ambient temperature in Zululand) respectively. All the extracts were assayed
for antifungal activity over a period of seven days.
5.2.2 Boiled extracts
Activity of boiled extracts was determined using the following procedure: One
gram of fresh plant material was placed in a volumetric (250 ml), containing
100 ml distilled water. The volumetric flask was closed with a glass funnel to
prevent over boiling. All prepared extracts were boiled for 10 minutes, then
cooled and filtered using Whatman No. 1 filter paper.
5.2.3 Masking Tests
Allium sativum and Tulbaghia vio/acea extracts were prepared as in Chapter
3. One millilitre of each was added to a one ml sucrose solution and one ml of
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flavouring (Robertsons' mint, strawberry and vanilla). These masked extracts
where then tested for antifungal activity.
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5.3 RESULTS AND DISCUSSION
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Stability testing of extracts was performed in order to determine the activity of
the extracts in solution over a period of time. Aqueous extracts were chosen
for the stability testing given that a formulation would have to be prepared by
patients in their homes and it would also need to be an easy and safe
preparation. Allium sativum extracts remained active in solution for three days
at all three temperatures. However, it was evident that the extract stored at
4QC remained stable for considerably longer periods than the extracts stored
at 23 Q C and 33 Q C (Figure 5.3.1). When garlic is extracted at room
temperature the major product is allicin (alkyl-2propene-thiosulphinate) which
is formed by enzymatic action on alliin in the crushed tissue, and which has
marked antibacterial, antiviral and antifungal activity. Allicin is very unstable
and can undergo a variety of transformations, which results in products such
as the ajoenes (BURTON AND KAYE, 1992). This therefore leads to stored
extract solutions loosing their activity with time, as the allicin is transformed.
The findings in this study confirms the work performed by Davis et al. (1994),
where concentrated garlic extracts stored at low temperatures retained activity
for a week and there after lost activity significantly. Extracts where biologically
stable when frozen, but lost three-fourths of their biological potency when held
at room temperature (DAVIS et al., 1994).
Tulbaghia violacea remained stable in solution for an average of two days at
the different temperatures (Figure 5.3.2). As with A. sativum, the extracts of T.
violacea stored at 4QC remained stable for more days than those stored at
Chapter 5 Stability of extracts from most active plants 61
23°C and 33°C. T. violacea is also known to contain low molecular mass
compounds which possess bacteriostatic activity. This activity is attributed to
the sulphur compounds (BURTON AND KAYE, 1992). T. violacea has been
reported to have presence of a carbon-sulphur lyase enzyme with similar
action to that present in Allium cepa and A. sativum, which is hydrolysed to
alkyl thiosulphinate and responsible for the biological activity (BURTON AND
KAYE, 1992).
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Figure 5.3.1 Stability of Allium sativum aqueous extracts over a one-
week period against Candida albicans strains at different temperatures.
(A) 5-month-old baby strain, (B) adult strain, (C) ATCC 10231. (circle)
4°C, (square) 23°C and (triangle) 33°C.
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Figure 5.3.1 Stability of Tulbaghia violacea aqueous extracts over a one-
week period against Candida albicans strains at different temperatures.
(A) 5-month-old baby strain, (8) adult strain, (C) ATCC 10231. (circle)
4°C, (square) 23°C and (triangle) 33°C.
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On the other hand G. glabra and P. myrtifolia were less stable. Both extracts
lost activity within a 24 h period when stored non-refrigerated.
The results show that it would be necessary to prepare fresh extracts of G.
glabra and P. myrtifolia on a daily basis, whereas extracts of A. sativum could
be stored for two days and those of T. violacea for three to four days
depending on the temperature of storage area. It would obviously be
advantageous to be able to store the extracts for longer periods of time, and
further the extracts of T. violacea would be preferred based on their stability in
solution.
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Figure 5.3.1 Stability of Glycyrrhiza glabra aqueous extracts over a one-
week period against Candida albicans strains at different temperatures.
(A) 5-month-old baby strain, (8) adult strain, (C) ATCC 10231. (circle)
4°C, (square) 23°C and (triangle) 33°C.
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Figure 5.3.1 Stability of Polygala myrtifolia aqueous extracts over a one-
week period against Candida albicans strains at different temperatures.
(A) 5-month-old baby strain, (B) adult strain, (C) ATCC 10231. (circle)
4°C, (square) 23°C and (triangle) 33°C.
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Boiled extracts
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Difference in activity was evident with the boiled and fresh extracts of A.
sativum (Figure 5.3.5). For all the three strains tested the activity of the boiled
extracts was found to have MIC values of >25 mg/ml respectively, whilst fresh
extracts had MIC values of 0.78 mg/ml, 3.25 mg/ml and 6.25 mg/ml for the
strain from a 5-month-old, strain from an adult and standard (ATCC 10231)
strain respectively.
Results obtained for Polygala myrtifolia boiled and fresh leaf extracts were
similar to those observed in A. sativum, where the MIC values increased after
boiling The MIC value increased after boiling (Figure 5.3.6). Boiling of the
extracts could possibly inactivate the enzymes that breakdown saponins, the
presumed active agents in P. myrtifolia, therefore leading to reduced activity in
extracts.
Masking tests
Addition of sucrose and flavouring enhanced the extracts of A. sativum and T.
violacea in sweetness, but this did not change the aftertaste and smell left by
the active sulphur compound. Anticandidal activity was performed on the
adulterated extracts. These extracts maintained activity without change in the
MIC values when screened (Table 3.3.1). Extracts of P. myrtifolia did not have
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an unpleasant taste or smell and extracts of G. glabra had a natural pleasant
taste of liquorice, and therefore did not require masking.
The stigma attached to being infected with HIV/AIDS in the community lead to
the attempt to masking the sulphur containing plant extracts. Those infected
by the virus would have to remain unknown to the public and therefore, the
failure to mask the two garlic extracts lead to the consideration of G. glabra
and P. myrtifolia to be used in the clinical trials.






















Figure 5.3.5 Antifungal activity of Allium sativum fresh aqueous and


























Figure 5.3.6 Antifungal activity of Polygala myrtifolia fresh aqueous
extracts and boiled extracts against Candida albicans.
CHAPTER 6
CONCLUSION
An anticandidal assay was successfully set up and 24 traditionally used South
African plants were screened against Candida albicans. Allium sativum,
Tulbaghia violacea, Glycyrrhiza glabra and Polygala myrtifolia had the best
activity. A. sativum and T. violacea were the most stable in solution when stored
at a lower temperature of 4QC. However, the smell and bitter taste of garlic could
however not be masked from both extracts. This odour leads to HIV/AIDS
patients being identified. Due to the stigma attached to being infected by
HIV/AIDS identification of patients by community members is not advised. These
two plant extracts therefore had to be eliminated from use as mouthwash.
Glycyrrhiza glabra and Polygala myrtifolia on the other hand did not need
masking due to their pleasant smell and taste; G. glabra with the natural pleasant
taste and smell of liquorice. Although these saponin containing extracts were not
stable in solution for periods over 24 hours, they where however further
investigated for use as mouthwash in homes and hospitals.
The presence of saponins and the assumption of these compounds as the active
constituents in both Glycyrrhiza glabra and Polygala myrtifolia extracts, support
the study of anticandidal compounds on other plant species known to contain
saponins. The screening of Glycyrrhiza glabra for anticandidal activity is a further
indication of its vast biological importance. Saponins in P. myrtifolia and its ability
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to inhibit Candida albicans and its use as an anticandidal formulation could be
justified by the use of Polyga/a fruticosa as an antifungal agent in traditional
medicine.
Performance of stability tests on the extracts was of crucial importance to enable
users to know the effects of temperature on the formulation and therefore know
the precautions to take when preparations are made. After determining the
stability status of the extracts, they were all found to maintain activity better when
stored at lower temperatures. This was therefore an important step in
determining the fact that daily preparations of extracts would have to be made.
Findings of this project could therefore lead to further studies on plants with
anticandidal activity, paying special attention to species in the Alliaceae family
and those which contain saponins. Secondly findings from this project could lead
to the specific isolation of the active constituents from each active plant extract.
Most importantly, findings from this project are a source of alternative antifungal
remedies for HIV/AIDS patients, who cannot afford presently available antifungal
agents and to those who find presently available antifungal agents ineffective.
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1.75 9 Barium chloride made up to 100 ml distilled water.
Solution B
1 ml sulphuric acid made up to 100 ml of distilled water
Add 0.5 ml Solution A with 99.5 ml Solution B, mix well and then dispense into
a sealed container. Store in a dark place at room temperature. The solution
should be replaced every 3 months.
